The influence of 6-months treatment with exenatide on type 2 diabetes mellitus compensation, anthropometric and biochemical parameters

Abstract

Exenatide, a synthetic GLP-1 analogue, is a new antidiabetic agent from the group of incretine mimetics ciming into the daily clinical practice. In our study we evaluated the effect of 6-monaths treatment with exenatide on diabetes compensation, anthropometric and biochemical parameters in the patients with poorly controlled type 2 diabetes mellitus and obesity.

Keywords

• Exenatide
• GLP-1
• type 2 diabetes mellitus
• body weight
• obesity